MyoKardia (MYOK) – Business Wire
-
Bristol Myers Squibb Reports Third Quarter 2020 Financial Results
-
Bristol Myers Squibb and MyoKardia Announce Expiration of HSR Act Waiting Period
-
Bristol Myers Squibb to Acquire MyoKardia for $13.1 Billion in Cash
Back to MYOK Stock Lookup